Close Menu
Home » Study Validates Oncotype DX AR-V7 Chemo Prediction

Study Validates Oncotype DX AR-V7 Chemo Prediction

Jun 28, 2018
|
staff reporter

NEW YORK (GenomeWeb) – A newly published  multi-institutional cohort study has validated Epic Sciences' circulating tumor cell-based AR-V7 test, now marketed by Genomic Health as Oncotype DX AR-V7 Nucleus Detect.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

"Slowdown"of Data Sharing

The General Data Protection Regulation has slowed some data sharing with non-European researchers as they find ways to comply with the law, ScienceInsider reports.

Ethicist Argues for Germline Changes

A bioethicist from Abertay University uses a utilitarian approach to justify genetically modifying the human germline, the BBC reports.

To Keep Track

The US has upgraded its network of public health labs to provide whole-genome sequencing to track antibiotic-resistant bacteria, Quartz reports.

Science Studies Present Method to Visualize 3D Genome Structure, RNAi Screens to Study Insect Horns

In Science this week: approach to visualize 3D genome structure in single cells, RNA interference knockdown screens to examine genetic origins of beetle horns and insect wings,  and more.

Dec
02
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of   FLT3  and  CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Dec
04
Featured Webinar

Integrating Genetic Data in Clinical Workflows: How CCPM Established a Personalized Health Framework

Sponsored by
BC Platforms

This webinar will discuss what it takes to begin realizing precision medicine in a comprehensive clinical infrastructure, with insights from the Colorado Center for Personalized Medicine (CCPM).

Dec
11
Featured Webinar

Advances in Precision Oncology: Tertiary Analysis Software for Solid Tumor NGS

Sponsored by
Roche

This webinar will address how two molecular laboratories are implementing tertiary analysis software to improve their precision oncology workflows.

What's Popular?

In Molecular Diagnostics

  1. Despite FDA Clearance for NantHealth Test, Benefits of TMB Biomarker Unclear

    Premium

  2. Myriad Genetics BRACAnalysis Approved by Japanese Regulators

  3. T2 Biosystems Gets CE Mark for Direct-From-Blood Antimicrobial Resistance Panel

  4. Cancer Diagnostics Firm Lucence Raises $20M

  5. Exact Sciences Marker Panel Detects Early Liver Cancer With Triple Sensitivity of Current Biomarker

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.